Clovis Oncology Profit Margin 2010-2021 | CLVS
Current and historical gross margin, operating margin and net profit margin for Clovis Oncology (CLVS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Clovis Oncology net profit margin as of June 30, 2021 is -197.75%.
|Clovis Oncology Annual Profit Margins
|Clovis Oncology Quarterly Profit Margins
||Medical - Biomedical and Genetics
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.